Literature DB >> 9179624

Surfactant prevents quartz induced down-regulation of complement receptor 1 in human granulocytes.

G Zetterberg1, J Lundahl, T Curstedt, A Eklund.   

Abstract

Quartz is known to induce an inflammatory response in the alveolar space by recruitment of different effector cells. We investigated the interaction between granulocytes and quartz with respect to expression of complement receptor type 1 (CR1) and CR3, with and without the presence of surfactant. Granulocytes from hemolyzed blood were stimulated by N-formyl-methionyl-leucyl-phenylalanine (fMLP), which mobilize the intracellular pool of CR1 to the surface, and the mean fluorescence intensity (MFI) measured by cytofluorometry was 47.4 (46-63.6) (median; interquartile range). Quartz exposure reduced the CR1 expression to 23.2 (22.8-30.6) MFI units (P < 0.01), a porcine surfactant preparation added during quartz exposure abolished the down-regulation completely, 47.7 (43.2-62.3) MFI units (P < 0.001). Similar results were obtained after preincubation of the cells with surfactant followed by quartz exposure. No significant influence on CR1 expression was found by a synthetic lipid mixture, nor was the CR3 expression affected. In conclusion, this study demonstrates that the presence of surfactant inhibits quartz induced down-regulation of CR1 on activated granulocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179624     DOI: 10.1023/a:1027394926261

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  35 in total

Review 1.  Complement receptors.

Authors:  M Krych; J P Atkinson; V M Holers
Journal:  Curr Opin Immunol       Date:  1992-02       Impact factor: 7.486

Review 2.  Structure and function of the leukocyte adhesion molecules CD11/CD18.

Authors:  M A Arnaout
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

3.  Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.

Authors: 
Journal:  Pediatrics       Date:  1988-11       Impact factor: 7.124

4.  Immunomodulation by pulmonary surfactant.

Authors:  A Catanzaro; P Richman; S Batcher; M Hallman
Journal:  J Lab Clin Med       Date:  1988-12

5.  Silica decreases phagocytosis and bactericidal activity of both macrophages and neutrophils in vitro.

Authors:  B T Zimmerman; B P Canono; P A Campbell
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

6.  Regulation of lung fibroblast proliferation and protein synthesis by bronchiolar lavage in experimental silicosis.

Authors:  S C Benson; J C Belton; L G Scheve
Journal:  Environ Res       Date:  1986-10       Impact factor: 6.498

7.  Quartz exposure, retention, and early silicosis in sheep.

Authors:  R Bégin; A Dufresne; A Cantin; F Possmayer; P Sébastien; D Fabi; G Bilodeau; M Martel; D Bisson; B Pietrowski
Journal:  Exp Lung Res       Date:  1989-05       Impact factor: 2.459

8.  Presence of serum modulates expression of complement receptor type 1 (CR1) on human granulocytes after quartz exposure.

Authors:  J Lundahl; A Eklund; J Hed; G Tornling; M Vitas
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

9.  Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf).

Authors:  C P Speer; B Götze; T Curstedt; B Robertson
Journal:  Pediatr Res       Date:  1991-07       Impact factor: 3.756

10.  Kinetics of the bronchoalveolar leucocyte response in rats during exposure to equal airborne mass concentrations of quartz, chrysotile asbestos, or titanium dioxide.

Authors:  K Donaldson; R E Bolton; A Jones; G M Brown; M D Robertson; J Slight; H Cowie; J M Davis
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

View more
  1 in total

1.  Lysophosphatidylcholine abrogates the CR1 preserving effect of surfactant on quartz-exposed human granulocytes.

Authors:  G Zetterberg; T Curstedt; J Lundahl; A Eklund
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.